CORC

浏览/检索结果: 共373条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Design and Performance Evaluation of a Novel Vascular Robotic System for Complex Percutaneous Coronary Interventions 会议论文
Mexico, 2021.11.1 - 2021.11.5
作者:  Han-Lin Zhao;  Shi-Qi Liu;  Xiao-Hu Zhou,;  Xiao-Liang Xie;  Zeng-Guang Hou
收藏  |  浏览/下载:19/0  |  提交时间:2022/06/15
Applications of Compact Laser Plasma Accelerator (CLAPA) Beamline in Peking University 会议论文
Australia, 2019
作者:  D.Y. Li;  J.E. Chen;  Y.X. Geng;  X.Y. Hu;  C.C. Li
收藏  |  浏览/下载:30/0  |  提交时间:2019/08/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:45/0  |  提交时间:2019/12/05
Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria 会议论文
作者:  Gu Wenyi;  Deng, Guohong;  Zheng, Xin;  Chen, Jinjun;  Wang, Xian-bo
收藏  |  浏览/下载:88/0  |  提交时间:2019/12/05
The Analysis of the Evaporation Effect on Moisture Soil under Intermittent Operation of Ground-source Heat Pump 会议论文
INNOVATIVE SOLUTIONS FOR ENERGY TRANSITIONS, 2019-01-01
作者:  Shang, Yan;  Dong, Ming;  Mu, Lin;  Liu, Xiaohua;  Huang, Xiaowan
收藏  |  浏览/下载:28/0  |  提交时间:2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:35/0  |  提交时间:2019/12/05
A general selection method for mutation strategy in differential evolution 会议论文
作者:  Xia, Dahai;  Lin, Song;  Yan, Meng;  Xiong, Caiquan;  Li, Yuanxiang
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
A Parameter Estimation of Fractional Order Multivariate Grey Model with Time-delay Based on Adaptive Dynamic Cat Swarm Optimization 会议论文
作者:  Li, An-Sheng;  Gao, Fei;  Wang, Meng;  Lin, Bin-Yan
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace